Abstract: The present study was designed to compare the effects of low-level laser with occlusal splints in patients with signs and symptoms of myofascial pain (MP) dysfunction syndrome. A total of 40 (34 women and 6 men, with a mean age of 32.84 [SD, 10.70] years) were selected after the diagnosis of MP according to the Research Diagnostic Criteria for Temporomandibular Disorder. The patients were randomly divided into 2 groups: study group (n = 20) and control group (n = 20). Low-level laser was applied to patients in the study group 2 times per week, for a total of 10 sessions. Patients in the control group were instructed to wear occlusal splints 24 h/d for 3 months. The functional examination was based on Research Diagnostic Criteria for Temporomandibular Disorder and pressure pain threshold values were obtained with the aid of an algometer in both groups. Patients' self-report of pain was evaluated with visual analog scale. Comparisons were made within and between the groups before and after treatment. Vertical movements showed statistically significant improvements after the treatments in both groups (P G 0.01), but when the groups were compared with each other, there were no significant difference between the groups. In both groups, tenderness to palpation of the muscles decreased significantly. Pressure pain threshold evaluations and visual analog scale scores revealed similar results, too. This particular type of low-level laser therapy (820 nm, 3 J/cm 2 , 300-mW output power) is as effective as occlusal splint in pain release and mandibular movement improvement in MP.
M yofascial pain (MP) can be considered the most common temporomandibular disorder (TMD) . Although the precise etiology of MP is not known, microtrauma and macrotrauma (occlusal interferences, nocturnal bruxism, and physical overloading of the muscles) and systemic factors (psychiatric illness and emotional stress) have been identified as possible underlying factors.
1Y3
Approaches to MP treatment are complex, depending on the extent of muscle damage and the duration and severity of symptoms. Treatment goals of MP syndrome (MPS) include diminishing pain, restoring function, and enabling the patient to resume daily activities. Conservative treatment methods, including occlusal splints, physical therapy, feedback, acupuncture, and short-term pharmacotherapy, are often used initially.
Occlusal splints (also known as muscle relaxation appliance) constitute the primary treatment modality for TMD patients, including patients with MP. The positive effects of occlusal splints on masticatory muscles were well documented in previous studies, 4Y7 which reported significant alterations in masticatory muscle activity. Okeson 8 provided an extensive discussion of the mechanisms of action of occlusal splints and proposed different hypotheses to explain their effects. Recent clinical studies demonstrated that occlusal splints led to neuromuscular repositioning of the mandible and that the new position appeared more physiologically relevant.
9Y11
Physical therapy methods for the treatment of MP include transcutaneous electrical stimulation, ultrasound, exercises, acupuncture, and low-level laser. The use of low-level laser therapy (LLLT) in muscular and myalgic disorders has been documented in the literature for more than 3 decades. In a clinical study by Pinheiro et al, 12 LLLT was applied to 241 patients with different types of maxillofacial disorders twice a week for a total of 12 sessions; LLLT was beneficial with regard to many pain conditions. The hypothesis that LLLT has analgesic, myorelaxant, tissue healing, and biostimulation effects is supported by numerous placebocontrolled clinical studies. 13Y15 On the other hand, a number of studies have reported controversial results. 16, 17 Gam et al 18 reported that laser light cannot penetrate into deeper structures and that laser light is not beneficial in MPS. This contradiction may be explained by variation in power intensity, exposure times, and location of laser application.
It is difficult to compare the results from previous LLLT studies because of a lack of standardization and no consensus with regard to a precise laser therapy protocol. The aims of the present study were to evaluate the efficiency of LLLT and compare it with occlusal splints in the treatment of MP. Herein, we tested the null hypotheses that pain intensity and muscle tenderness do not decrease when the patients are exposed to LLLT and that LLLT is not a beneficial alternative treatment for MP.
MATERIALS AND METHODS

Experimental Subjects
The present study was performed at the Department of Maxillofacial Prosthodontics, School of Dentistry, University of Istanbul. The ethics committee of Istanbul Faculty of Medicine, Istanbul University, approved the protocol (project 2007/2103). Written informed consent was obtained from each subject after a ORIGINAL ARTICLE full explanation of the study. Between January 9, 2007, and January 3, 2008, 381 patients were examined for temporomandibular pain treatment (Fig. 1) . The patients came to the clinic because of orofacial pain, or they were referred from other disciplines for TMD treatment. Sixty-five patients fulfilled the inclusion criteria, but 21 of the qualifying patients refused to participate in the study. Forty-four patients were included in the study and were randomly divided into 2 groups. Patients in both groups were age and sex matched. A standardized clinical examination that included patient history, temporomandibular joint (TMJ) and masticatory muscle palpation, and examination of mandibular movements was used for patient selection. The first examination was used to evaluate whether the subjects fulfilled the inclusion criteria. The second examination was used to collect data. The inclusion criteria were (1) diagnosis of MP according to the Research Diagnostic Criteria for Temporomandibular Disorder (RDC/TMD) 19 ; (2) between 18 and 60 years of age; (3) with natural posterior occlusion; (4) no TMD treatment in the last 2 years; and (5) with orofacial pain for at least 6 months. Exclusion criteria were (1) TMD of articular origin diagnosed according to RDC/TMD; (2) with psychiatric disorders, heart disease, or pacemakers; (3) removable prosthesis or the absence of more than 1 tooth per quadrant and major malocclusion (anterior open bite, unilaterally maxillary lingual crossbite, overjet 96 mm, slide from the retruded contact position to intercuspal position 92 mm); (4) pregnancy; (5) symptoms that could be caused by other orofacial region diseases (eg, toothache, neuralgia, migraine); (6) treatment or any medication for headache or bruxism during the previous year; and (7) local skin infections over the masseter muscle. During the course of the study, patients were asked not to take any analgesics or pain treatments and to adhere strictly to the study protocol.
Study Protocol
The present study was designed as a randomized, double-blind clinical trial. Randomization was done before the arrangements for the date of therapy were made. Selection bias was considered through a defined and concealed randomization process. The patients did not know if they were assigned to the study or control group and which group was study and which group was control. Assessment of the participants was conducted by an independent investigator who was unaware of the study. Patients in the study group (n = 20) were treated with laser application, and patients in the control group (n = 20) were treated with occlusal splints. The patients were evaluated 2 times: 30 minutes before the first session and 30 minutes after the last session of assigned therapy. The functional examination, determination of pressure pain threshold (PPT), and visual analog scale (VAS) scores were performed as described in the following section.
Testing Criteria
The functional examination was based on RDC/TMD. 19 The suggested translation of RDC/TMD by the International RDC-TMD Consortium was used in this study. All patients were examined by an experienced prosthodontist who has been using RDC/TMD for more than 5 years. The clinician was calibrated before the study using RDC/TMD as the criterion standard. The patients were asked to report any pain during muscle palpations and mandibular movements, and their answers were recorded according to the verbal scale. The degree of pain under palpation was rated as 0, no pain; 1, mild pain; 2, moderate pain; and 3, severe pain.
A dial algometer (Wagner Pain Test Model FPK Algometer, Wagner Instruments, Greenwich, CT) was used to measure the PPT on masticatory muscles. The clinician calibrated the algometer before measurements were taken. Pressure pain threshold measurements were obtained by applying pressure to the same points used in the palpation of masseter muscle (superior point, middle point, inferior point) and at one point in the temporalis anterior point on both sides before and after treatment. The compressions were performed using 1-cm 2 rubber tip. Before the first session, a few test measurements were performed on the lower arms. The patients were instructed to use their hands to indicate immediately when the pressure became painful; application of pressure was then stopped. After a 30-second resting period, the next measurement was taken. The PPT values were recorded as kilograms per centimeter squared. In the present study, patients' subjective reports of pain were evaluated with RDC/TMD Axis II criteria and VAS.
Laser Exposure
An experienced clinician who was trained in LLLT (Department of Oral Diseases) performed the procedure. A continuous lowintensity semiconductor (Doris Diode Laser, CTL 1106 MX; Warsaw, Poland) that generates continuous radiation with regulated power was used as the laser source. The single-probe laser device applied a laser diode-generating infrared radiation wavelength of 820 nm. The beam diameter of the device was 6 mm, and the probe had an angle of 45 degrees. The energy intensity given to each muscle point was adjusted to 3 J/cm 2 by applying 300-mWoutput power for 10 seconds. Low-level laser therapy was applied precisely and continuously onto the trigger points. Patients were exposed to laser application from a 2-mm distance while seated in a dental chair with their necks supported, 2 times per week, for a total of 10 sessions.
Occlusal Splint Therapy
Stabilization splints were fabricated as described by Okeson, 8 and the patients were instructed to wear the occlusal splints 24 h/d for 3 months. Patients were called back for follow-up visits at 7, 30, and 90 days after splint insertion. When necessary, additional adjustments were performed. Data were collected before the splint was inserted and at 90 days after insertion.
Statistical Analyses
For all statistical tests, NCSS 2007 and PASS 2008 Statistical & Power Analysis Software (NCSS, Kaysville, UT) were used. All variables were analyzed descriptively. Descriptive statistical methods (mean, SD, and frequency) were applied. For the comparison of quantitative data, Student t tests were performed for betweengroup comparisons of parameters showing a normal distribution, and Mann-Whitney U tests were performed for between-group comparisons of parameters showing a nonnormal distribution. For the FIGURE 1. Flowchart of the patients in the study.
comparative evaluation of parameters showing normal distributions within the group, paired-samples t tests were performed. For the comparative evaluation of parameters showing nonnormal distributions, Wilcoxon signed rank tests were performed. For the quantitative variables, this analysis was made using W 2 and Fisher exact tests. For the evaluation of associations between the parameters, Spearman Q test was used. The results were analyzed at a 95% confidence interval, and the significance level was set at P G 0.05.
RESULTS
The present study included 44 MPS patients (34 women and 6 men). However, 4 of the patients did not complete the treatments; they did not show up at all visits. Forty patients' data were analyzed.
The demographic features of the study participants are shown in Table 1 , and the pain condition of the patients in Tables 2 and 3 . We did not identify any statistically significant differences between the study and control groups with regard to age, sex, education, or marital status. There was a predominance of women in both groups. The pain condition of the patients did not differ before study between the groups. Furthermore, they did not show any statistically significant differences after treatment.
Mandibular movements and associated pain, tenderness upon palpation in masticatory muscles, and PPTs were assessed in both groups of patients. Both groups showed statistically significant improvements in vertical movements after treatment (P G 0.01); no significant differences in vertical movements were identified between the 2 groups (Table 4) . No significant difference in pain by palpation of the muscles was identified between the groups either before or after treatment (P 9 0.05). In both groups, tenderness to muscle palpation (Tables 5 and 6 ) and PPT evaluations (Table 7) both decreased significantly after treatment. The results of overall pain ratings on a visual analog scale (VAS) demonstrated statistically significant improvements in both groups (Table 8) . A statistically significant difference in RDC/TMD Axis II evaluation was not identified between the 2 groups (P 9 0.05) ( Table 9) . None of the patients reported any adverse effects related to laser application or occlusal splint use during or after the treatment period.
DISCUSSION
Our study was designed to investigate the clinical effect of LLLT treatment (820 nm, 3 J/cm 2 , 300-mW output power) involving direct application on painful masticatory muscles. Patients who received laser application as well as occlusal splints did benefit from the therapy. Objective and subjective criteria were considered for the evaluation of treatment effectiveness, including mandibular movements and pain and muscle tenderness to palpation and to digital palpation. Significant improvements were obtained in the tested parameters both in the study and control groups. Furthermore, VAS scores decreased after laser application. The prevalence of MPS has been assessed in epidemiologic surveys, and age-and sex-related differences in MPS occurrence were identified. 20Y24 Myofascial pain syndrome has a higher prevalence in females, with a peak incidence at middle age. In the present study, the age of the patient population was between 19 and 54 years, with a mean age of 32.84 (SD, 10.70) years; this result is in agreement with previous reports that MPS is seen primarily during the second and third decades of life (between 26 and 28 years of age). 24Y26 In a recent study, Janal et al 27 examined the prevalence of MPS in 19,564 nonpatient US community women. The ratio of females in RDC-defined MPS was 10.5%, which was in accordance with the results of Schmitter et al, 28 but lower than the ratios reported by Rantala et al 29 (20%) and MacFarlane et al 30 (18.4%) . The reported prevalence of females within MPS patient populations is much higher. In a clinical study examining the demographic features in a group of subjects with cervical MPS, the authors reported a prevalence of 87.8% females. 24 Attempts have been made to explain the difference in terms of behavioral, psychosocial, hormonal, and constitutional characteristics. In the present study, 34 of the 40 MPS patients were female (85%) and 6 were male (15%), which is similar to previous reports.
Radiographs, computed tomography and magnetic resonance imaging have been established as diagnostic tools for identifying TMJ and related structures, but these methods are not useful for diagnosing muscle disorders. It is universally accepted that muscle disorders are most effectively diagnosed by clinical examination. However, a diagnosis of MP by muscle palpation is challenging. Muscle palpation can lead to unreliable results, and muscle tenderness can change spontaneously over time. It is often difficult to identify the same symptom during successive examinations. 31 In the present study, measurements of muscle tenderness and mandibular mobility were made by the same experienced clinician, who was a TMD specialist. Furthermore, the clinician used a calibrated RDC/ TMD approach, which is the criterion standard. Dworkin et al 32 demonstrated the importance of examiner training for reliable assessment of TMD signs and symptoms. Study reliability increases when all of the muscle palpations are performed by the same experienced, competent clinician who is specialized in TMD treatment and examination methods. 32 However, a quantitative method, such as PPT, for evaluating muscle pain and tenderness would enhance the clinical assessment of MPS.
Pressure pain threshold is defined as the minimum amount of applied pressure that induces pain. Various algorithms, both simple and sophisticated, have been developed to evaluate PPT; pressure algometry (PA) is the most common algorithm for assessing PPT. Many clinical studies examining the effect of treatment used PA to evaluate pretreatment and posttreatment conditions. 33Y36 Goulet and Clark 36 reported that PA was more reliable than manual palpation in evaluating muscle tenderness. In a recent study, Visscher et al 37 compared algometry with palpation in the diagnosis of TMD pain in 250 patients and demonstrated that PA results were comparable to palpation results. Similar results were obtained in the present study: palpation results and PPT values for masticatory muscle sides were comparable before and after treatment. This result supports the hypothesis that an experienced, well-trained clinician can perform reliable palpations.
Many randomized and nonrandomized, double-blind clinical studies have been carried out to investigate the effects of LLLT on arthrogenic and muscle disorders. Simunovic 38 reported that patients treated with LLLT recovered more rapidly and experienced enhanced pain relief compared with untreated patients. The molecular mechanisms underlying the significant analgesic effect on muscles by LLLT are not understood, but may be associated with increased adenosine triphosphate production by mitochondria, increased electrical potential of the mitochondria membrane, 39 and increased serotonin and endorphins. 40 Furthermore, local blood circulation was reported to increase in response to LLLT. 41 Whether LLLT is an effective MP treatment remains controversial. Several clinical studies have reported favorable results using LLLT for the treatment of muscle pain. 15, 38, 42, 43 There is insufficient evidence on the effective dose, duration, type, and frequency of low-intensity laser used in the treatment of muscle disorders. Different wavelengths, including 632.8-nm neon-helium laser 16 and 660-, 15 780-, 44, 45 810-, 46 904-, 47 and 830 to 904-nm soft laser 43 have been used and were reported to be effective in managing TMD. In the present study, we used a wavelength (820 nm) that was within the wavelength interval recommended for deep tissues, but higher than the recommended wavelength for trigger points. 48 By using a higher wavelength, we attempted to compensate for decreased penetration of the laser light. This dosage showed beneficial results with respect to muscle pain. There is still a lack of published evidence for the apparent effective low-intensity laser dose for MPS.
The promising results of the present study support previous findings that LLLT is an effective treatment for muscle pain that also improves vertical mandibular movement. The null hypothesis was rejected in the present study. Objective and subjective parameters were used to evaluate the effect of LLLT in patients with MP, and PPT increased significantly after laser exposure. Furthermore, measured clinical parameters showed improvement, and muscle pain in response to palpation decreased significantly after LLLT. These improvements may be explained by the analgesic and biostimulating effects of LLLT.
Various types occlusal splints with different indications and functions have been safely used for MPS treatment. Stabilization splints and 1 type of occlusal splint, also known as Michigan splints or centric relation splints, normalize aggravated sensory and proprioceptive impulses generated by the occlusion. 49 In the present study, stabilization splints were used to provide an ideal removable occlusion. Statistically significant improvements in muscle pain reduction and mandibular movements were shown in patients treated with occlusional splints in the present study.
The present study does have some limitations. The patients in the stabilization splint and LLLT groups were not evaluated at the same time. Ideally, when 2 treatment groups are compared, the data collection and treatment period should occur at the same time for both groups. However, in the present study, the treatment time for the LLLT was shorter than that for the occlusal splint group (90 days). This difference in treatment time is due primarily to the fact that the treatment effect of the assigned therapies was compared with each other. The LLLT duration was shorter than the occlusal splint therapy duration. We did not want to wait 4 weeks to assess the results of LLLT. Because if LLLT was not effective, the patients in the LLLT group would have received a more suitable treatment as soon as possible; this is the main reason why the 2 groups were evaluated at different periods. Low-level laser therapy is a noninvasive, rapid, and safe nonpharmaceutical treatment method that may be beneficial for patients with MPS. There is only limited clinical evidence regarding posttreatment effects of LLLT on MPS. Future clinical trials should focus on the method of allocation, outcome assessment standardization, sample size, and duration of follow-up. Further research using standardized laser settings should be conducted to investigate the long-term effects of LLLT in myogenic cases.
CONCLUSIONS
The present randomized clinical trial demonstrated that this particular type of LLLT (820 nm, 3 J/cm 2 , 300-mW output power) was as effective as occlusal splints in the treatment MPS. Based on its noninvasive and nonpharmaceutical nature, LLLT could be an effective alternative to other conventional treatment modalities for myogenic disorders because of its analgesic and myorelaxant effects. However, further double-blind, randomized, placebo-controlled clinical studies evaluating the long-term effects of LLLT in myogenic cases should be conducted.
